blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3114118

EP3114118 - P-SUBSTITUTED ASYMMETRIC UREAS AND MEDICAL USES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.05.2021
Database last updated on 26.04.2025
FormerThe patent has been granted
Status updated on  19.06.2020
FormerGrant of patent is intended
Status updated on  17.02.2020
FormerExamination is in progress
Status updated on  17.08.2018
FormerRequest for examination was made
Status updated on  09.12.2016
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 09.10.2024  [2024/41]
Applicant(s)For all designated states
Helsinn Healthcare SA
Via Pian Scairolo 9
6912 Lugano-Pazzallo / CH
[2017/02]
Inventor(s)01 / GIULIANO, Claudio
Via Prudenziana 28/A
22100 Como / IT
02 / GARCIA RUBIO, Silvina
7 Bellflower Ct.
Princeton, NJ 08540 / US
03 / DAINA, Antoine
Quartier Sorge
Batiment Genopode
1015 Lausanne / CH
04 / GUAINAZZI, Angelo
170 Wood Avenue South
5th Floor
Iselin, NJ 08830 / US
05 / PIETRA, Claudio
Via Scalabrini No. 56
22100 Como / IT
 [2017/02]
Representative(s)M. Zardi & Co S.A.
Via G. B. Pioda, 6
6900 Lugano / CH
[N/P]
Former [2020/30]M. Zardi & Co S.A.
Via G. B. Pioda, 6
6900 Lugano / CH
Former [2017/02]Zardi, Marco
M. Zardi & Co. SA
Via Pioda 6
6900 Lugano / CH
Application number, filing date15711614.606.03.2015
[2017/02]
WO2015US19112
Priority number, dateUS201461949664P07.03.2014         Original published format: US 201461949664 P
[2017/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015134839
Date:11.09.2015
Language:EN
[2015/36]
Type: A1 Application with search report 
No.:EP3114118
Date:11.01.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 11.09.2015 takes the place of the publication of the European patent application.
[2017/02]
Type: B1 Patent specification 
No.:EP3114118
Date:22.07.2020
Language:EN
[2020/30]
Search report(s)International search report - published on:EP11.09.2015
ClassificationIPC:C07D403/12, C07D401/14, C07D405/14, C07D239/26, C07D405/12, C07D409/12, C07D409/14, C07D413/12, C07D241/12, C07D417/12, C07D417/14, C07D471/04, C07D401/06, C07D401/12, C07D211/58, C07D211/60, C07D211/94, C07D211/96, C07D213/00
[2020/08]
CPC:
A61P1/00 (EP); C07D211/58 (EP,EA,KR,US); C07D403/12 (EP,EA,US);
C07F7/0812 (EA,US); A61K31/17 (KR); A61K31/4453 (KR);
A61K31/497 (KR); A61P1/04 (EP); A61P1/08 (EP);
A61P1/10 (EP); A61P1/14 (EP); A61P1/16 (EP);
A61P11/00 (EP); A61P25/04 (EP); A61P25/16 (EP);
A61P25/30 (EP); A61P25/32 (EP); A61P25/36 (EP);
A61P29/00 (EP); A61P29/02 (EP); A61P3/00 (EP);
A61P3/02 (EP); A61P3/04 (EP); A61P3/06 (EP);
A61P3/10 (EP); A61P31/18 (EP); A61P35/00 (EP);
A61P43/00 (EP); A61P5/50 (EP); A61P7/00 (EP);
A61P9/00 (EP); A61P9/04 (EP); A61P9/10 (EP);
A61P9/12 (EP); C07D211/60 (EP,EA,KR,US); C07D211/94 (EP,EA,KR,US);
C07D211/96 (EP,EA,KR,US); C07D213/00 (EP,EA,US); C07D239/26 (EP,EA,KR,US);
C07D241/12 (EP,EA,US); C07D401/06 (EP,EA,KR,US); C07D401/12 (EP,EA,US);
C07D401/14 (EP,EA,KR,US); C07D405/12 (EP,EA,US); C07D405/14 (EP,EA,US);
C07D409/12 (EP,EA,US); C07D409/14 (EP,EA,KR,US); C07D413/12 (EP,EA,US);
C07D417/12 (EP,EA,US); C07D417/14 (EP,EA,US); C07D471/04 (EP,EA,US) (-)
Former IPC [2017/02]C07D401/06, C07C275/06, C07C275/26, C07D401/12, C07D211/58, C07D211/60, C07D211/94, C07D211/96, C07D213/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/02]
Extension statesBA26.08.2016
ME26.08.2016
Validation statesMA26.08.2016
TitleGerman:P-SUBSTITUIERTE ASYMMETRISCHE HARNSTOFFE UND MEDIZINISCHE VERWENDUNGEN DAVON[2017/02]
English:P-SUBSTITUTED ASYMMETRIC UREAS AND MEDICAL USES THEREOF[2017/02]
French:URÉES ASYMÉTRIQUES P-SUBSTITUÉES ET UTILISATIONS MÉDICALES DE CELLES-CI[2017/02]
Entry into regional phase26.08.2016National basic fee paid 
26.08.2016Designation fee(s) paid 
26.08.2016Examination fee paid 
Examination procedure29.07.2016Date on which the examining division has become responsible
26.08.2016Examination requested  [2017/02]
21.04.2017Amendment by applicant (claims and/or description)
17.08.2018Despatch of a communication from the examining division (Time limit: M04)
22.11.2018Reply to a communication from the examining division
05.04.2019Despatch of a communication from the examining division (Time limit: M02)
07.05.2019Reply to a communication from the examining division
01.08.2019Despatch of a communication from the examining division (Time limit: M02)
16.09.2019Reply to a communication from the examining division
18.02.2020Communication of intention to grant the patent
09.06.2020Fee for grant paid
09.06.2020Fee for publishing/printing paid
09.06.2020Receipt of the translation of the claim(s)
Opposition(s)23.04.2021No opposition filed within time limit [2021/26]
Fees paidRenewal fee
23.03.2017Renewal fee patent year 03
23.03.2018Renewal fee patent year 04
22.03.2019Renewal fee patent year 05
20.03.2020Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL22.07.2020
CY22.07.2020
EE22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
MK22.07.2020
MT22.07.2020
RO22.07.2020
RS22.07.2020
SI22.07.2020
SM22.07.2020
BG22.10.2020
IS22.11.2020
[2024/41]
Former [2024/22]AL22.07.2020
CY22.07.2020
EE22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
MK22.07.2020
RO22.07.2020
RS22.07.2020
SI22.07.2020
SM22.07.2020
BG22.10.2020
IS22.11.2020
Former [2023/30]AL22.07.2020
CY22.07.2020
EE22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
RO22.07.2020
RS22.07.2020
SI22.07.2020
SM22.07.2020
BG22.10.2020
IS22.11.2020
Former [2021/45]AL22.07.2020
EE22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
RO22.07.2020
RS22.07.2020
SI22.07.2020
SM22.07.2020
BG22.10.2020
IS22.11.2020
Former [2021/36]AL22.07.2020
EE22.07.2020
LT22.07.2020
LV22.07.2020
RO22.07.2020
RS22.07.2020
SI22.07.2020
SM22.07.2020
BG22.10.2020
IS22.11.2020
Former [2021/25]AL22.07.2020
EE22.07.2020
LT22.07.2020
LV22.07.2020
RO22.07.2020
RS22.07.2020
SM22.07.2020
BG22.10.2020
IS22.11.2020
Former [2021/22]EE22.07.2020
LT22.07.2020
LV22.07.2020
RO22.07.2020
RS22.07.2020
SM22.07.2020
BG22.10.2020
IS22.11.2020
Former [2021/10]LT22.07.2020
LV22.07.2020
RS22.07.2020
BG22.10.2020
IS22.11.2020
Former [2021/07]LT22.07.2020
Cited inInternational search[X]US6399619  (BERK SCOTT [US], et al);
 [X]WO2004064738  (ACADIA PHARM INC [US], et al);
 [X]WO2006014136  (ASTRAZENECA AB [SE], et al);
 [X]US2008227780  (GLESS RICHARD D [US], et al);
 [X]WO2009039461  (ACADIA PHARM INC [US], et al);
 [X]WO2011060397  (SCHERING CORP [US], et al);
 [X]WO2012113103  (HELSINN HEALTHCARE SA [CH], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.